Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

IAPs contain an evolutionarily conserved ubiquitin-binding domain that regulates NF-κB as well as cell survival and oncogenesis

Nature Cell Biology volume 10, pages 1309–1317 (2008)Cite this article

Abstract

The covalent attachment of ubiquitin to target proteins influences various cellular processes, including DNA repair, NF-κB signalling and cell survival1. The most common mode of regulation by ubiquitin-conjugation involves specialized ubiquitin-binding proteins that bind to ubiquitylated proteins and link them to downstream biochemical processes. Unravelling how the ubiquitin-message is recognized is essential because aberrant ubiquitin-mediated signalling contributes to tumour formation2. Recent evidence indicates that inhibitor of apoptosis (IAP) proteins are frequently overexpressed in cancer and their expression level is implicated in contributing to tumorigenesis, chemoresistance, disease progression and poor patient-survival3. Here, we have identified an evolutionarily conserved ubiquitin-associated (UBA) domain in IAPs, which enables them to bind to Lys 63-linked polyubiquitin. We found that the UBA domain is essential for the oncogenic potential of cIAP1, to maintain endothelial cell survival and to protect cells from TNF-α-induced apoptosis. Moreover, the UBA domain is required for XIAP and cIAP2–MALT1 to activate NF-κB. Our data suggest that the UBA domain of cIAP2–MALT1 stimulates NF-κB signalling by binding to polyubiquitylated NEMO. Significantly, 98% of all cIAP2–MALT1 fusion proteins retain the UBA domain, suggesting that ubiquitin-binding contributes to the oncogenic potential of cIAP2–MALT1 in MALT lymphoma. Our data identify IAPs as ubiquitin-binding proteins that contribute to ubiquitin-mediated cell survival, NF-κB signalling and oncogenesis.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Get just this article for as long as you need it

$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Figure 1: IAPs carry an evolutionarily conserved UBA domain that mediates Ub binding.
Figure 2: RING-mediated dimerization of XIAP and cIAP1 is required for Ub binding.
Figure 3: The UBA is required for IAP function.
Figure 4: The ability of XIAP to induce NF-κB is dependent on its UBA domain.
Figure 5: The UBA domain of cIAP2–MALT1 interacts with polyubiquitylated NEMO.

Accession codes

Accessions

Protein Data Bank

References

  1. Di Fiore, P. P., Polo, S. & Hofmann, K. When ubiquitin meets ubiquitin receptors: a signalling connection. Nature Rev. Mol. Cell Biol. 4, 491–497 (2003).

    Article  CAS  Google Scholar 

  2. Hoeller, D., Hecker, C. M. & Dikic, I. Ubiquitin and ubiquitin-like proteins in cancer pathogenesis. Nature Rev. Cancer 6, 776–788 (2006).

    Article  CAS  Google Scholar 

  3. Hunter, A. M., LaCasse, E. C. & Korneluk, R. G. The inhibitors of apoptosis (IAPs) as cancer targets. Apoptosis 12, 1543–1568 (2007).

    Article  CAS  Google Scholar 

  4. Cook, W. J., Jeffrey, L. C., Sullivan, M. L. & Vierstra, R. D. Three-dimensional structure of a ubiquitin-conjugating enzyme (E2). J. Biol. Chem. 267, 15116–15121 (1992).

    CAS  PubMed  Google Scholar 

  5. Varadan, R. et al. Solution conformation of Lys 63-linked di-ubiquitin chain provides clues to functional diversity of polyubiquitin signaling. J. Biol. Chem. 279, 7055–7063 (2004).

    Article  CAS  PubMed  Google Scholar 

  6. Salvesen, G. S. & Duckett, C. S. Apoptosis: IAP proteins: blocking the road to death's door. Nature Rev. Mol. Cell Biol. 3, 401–410. (2002).

    Article  CAS  Google Scholar 

  7. Vince, J. E. et al. IAP antagonists target cIAP1 to induce TNF-α-dependent apoptosis. Cell 131, 682–693 (2007).

    Article  CAS  PubMed  Google Scholar 

  8. Varfolomeev, E. et al. IAP antagonists induce auto-ubiquitination of c-IAPs, NF-κB activation, and TNF-α-dependent apoptosis. Cell 131, 669–681 (2007).

    Article  CAS  PubMed  Google Scholar 

  9. Petersen, S. L. et al. Autocrine TNF-α signaling renders human cancer cells susceptible to Smac-mimetic-induced apoptosis. Cancer Cell 12, 445–456 (2007).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Li, X., Yang, Y. & Ashwell, J. D. TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2. Nature 416, 345 (2002).

    Article  Google Scholar 

  11. Isaacson, P. G. & Du, M. Q. Gastrointestinal lymphoma: where morphology meets molecular biology. J. Pathol. 205, 255–274 (2005).

    Article  CAS  PubMed  Google Scholar 

  12. Hofer-Warbinek, R. et al. Activation of NF-κ B by XIAP, the X chromosome-linked inhibitor of apoptosis, in endothelial cells involves TAK1. J. Biol. Chem. 275, 22064–22068 (2000).

    Article  CAS  PubMed  Google Scholar 

  13. Gaither, A. et al. A Smac mimetic rescue screen reveals roles for inhibitor of apoptosis proteins in tumor necrosis factor-alpha signaling. Cancer Res. 67, 11493–11498 (2007).

    Article  CAS  PubMed  Google Scholar 

  14. Bertrand, M. J. et al. cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol. Cell 30, 689–700 (2008).

    Article  CAS  Google Scholar 

  15. Lucas, P. C. et al. Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-κB signaling pathway. J. Biol. Chem. 276, 19012–19019 (2001).

    Article  CAS  PubMed  Google Scholar 

  16. Kirkin, V. & Dikic, I. Role of ubiquitin- and Ubl-binding proteins in cell signaling. Curr. Opin. Cell Biol. 19, 199–205 (2007).

    Article  CAS  PubMed  Google Scholar 

  17. Swanson, K. A., Hicke, L. & Radhakrishnan, I. Structural basis for mono-ubiquitin recognition by the Ede1 UBA domain. J. Mol. Biol. 358, 713–724 (2006).

    Article  CAS  PubMed  Google Scholar 

  18. Ohno, A. et al. Structure of the UBA domain of Dsk2p in complex with ubiquitin molecular determinants for ubiquitin recognition. Structure 13, 521–532 (2005).

    Article  CAS  PubMed  Google Scholar 

  19. Raasi, S., Orlov, I., Fleming, K. G. & Pickart, C. M. Binding of polyubiquitin chains to ubiquitin-associated (UBA) domains of HHR23A. J. Mol. Biol. 341, 1367–1379 (2004).

    Article  CAS  PubMed  Google Scholar 

  20. Raasi, S., Varadan, R., Fushman, D. & Pickart, C. M. Diverse polyubiquitin interaction properties of ubiquitin-associated domains. Nature Struct. Mol. Biol. 12, 708–714 (2005).

    Article  CAS  Google Scholar 

  21. Silke, J. et al. The anti-apoptotic activity of XIAP is retained upon mutation of both the caspase-3- and caspase-9-interacting sites. J. Cell Biol. 157, 115–124 (2002).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Santoro, M. M., Samuel, T., Mitchell, T., Reed, J. C. & Stainier, D. Y. Birc2 (cIap1) regulates endothelial cell integrity and blood vessel homeostasis. Nature Genet. 39, 1397–1402 (2007).

    Article  CAS  PubMed  Google Scholar 

  23. Zender, L. et al. Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell 125, 1253–1267 (2006).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Zender, L. et al. Generation and analysis of genetically defined liver carcinomas derived from bipotential liver progenitors. Cold Spring Harb. Symp. Quant. Biol. 70, 251–261 (2005).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Eckelman, B. P., Salvesen, G. S. & Scott, F. L. Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family. EMBO Rep. 7, 988–994 (2006).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Birkey Reffey, S., Wurthner, J. U., Parks, W. T., Roberts, A. B. & Duckett, C. S. X-linked inhibitor of apoptosis protein functions as a cofactor in transforming growth factor-β signaling. J. Biol. Chem. 276, 26542–26549 (2001).

    Article  CAS  PubMed  Google Scholar 

  27. Yamaguchi, K. et al. XIAP, a cellular member of the inhibitor of apoptosis protein family, links the receptors to TAB1-TAK1 in the BMP signaling pathway. EMBO J. 18, 179–187 (1999).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Lu, M. et al. XIAP induces NF-κB activation via the BIR1/TAB1 interaction and BIR1 dimerization. Mol. Cell 26, 689–702 (2007).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Peschard, P. et al. Structural basis for ubiquitin-mediated dimerization and activation of the ubiquitin protein ligase Cbl-b. Mol. Cell 27, 474–485 (2007).

    Article  CAS  PubMed  Google Scholar 

  30. Zhou, H., Du, M. Q. & Dixit, V. M. Constitutive NF-κB activation by the t(11;18)(q21;q21) product in MALT lymphoma is linked to deregulated ubiquitin ligase activity. Cancer Cell 7, 425–431 (2005).

    Article  CAS  PubMed  Google Scholar 

  31. Noels, H. et al. A Novel TRAF6 binding site in MALT1 defines distinct mechanisms of NF-κB activation by API2middle dotMALT1 fusions. J. Biol. Chem. 282, 10180–10189 (2007).

    Article  CAS  PubMed  Google Scholar 

  32. Zhou, H. et al. Bcl10 activates the NF-κB pathway through ubiquitination of NEMO. Nature 427, 167–171 (2004).

    Article  CAS  PubMed  Google Scholar 

  33. Sun, L., Deng, L., Ea, C. K., Xia, Z. P. & Chen, Z. J. The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. Mol. Cell 14, 289–301 (2004).

    Article  CAS  PubMed  Google Scholar 

  34. Baens, M., Steyls, A., Dierlamm, J., De Wolf-Peeters, C. & Marynen, P. Structure of the MLT gene and molecular characterization of the genomic breakpoint junctions in the t(11;18)(q21;q21) of marginal zone B-cell lymphomas of MALT type. Genes Chromosomes Cancer 29, 281–291 (2000).

    Article  CAS  PubMed  Google Scholar 

  35. Young, S. S. et al. Genomic organization and physical map of the human inhibitors of apoptosis: HIAP1 and HIAP2. Mamm. Genome 10, 44–48 (1999).

    Article  CAS  PubMed  Google Scholar 

  36. Lucas, P. C. et al. A dual role for the API2 moiety in API2-MALT1-dependent NF-κB activation: heterotypic oligomerization and TRAF2 recruitment. Oncogene 26, 5643–5654 (2007).

    Article  CAS  PubMed  Google Scholar 

  37. Wu, C. J., Conze, D. B., Li, T., Srinivasula, S. M. & Ashwell, J. D. Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-κB activation [corrected]. Nature Cell Biol. 8, 398–406 (2006).

    Article  CAS  PubMed  Google Scholar 

  38. Silke, J. et al. Determination of cell survival by RING-mediated regulation of inhibitor of apoptosis (IAP) protein abundance. Proc. Natl Acad. Sci. USA 102, 16182–16187 (2005).

    Article  CAS  PubMed  Google Scholar 

  39. Hu, S. et al. cIAP2 is a ubiquitin protein ligase for BCL10 and is dysregulated in mucosa-associated lymphoid tissue lymphomas. J. Clin. Invest. 116, 174–181 (2006).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Li, M. et al. An essential role of the NF-κ B/Toll-like receptor pathway in induction of inflammatory and tissue-repair gene expression by necrotic cells. J. Immunol. 166, 7128–7135 (2001).

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We would like to thank Xiaolu Yang, David Komander, David Barford, Thomas Farkas, Ivan Dikic and Marja Jaattela for reagents, discussions and invaluable technical support. We thank Irene Scarfò for help with the cIAP1 zebrafish experiments, and Hyejin Cho and Beicong Ma for excellent technical assistance and help with the mouse tumour model. We thank Alan Ashworth and members of the Meier laboratory for critical reading of the manuscript and helpful discussions. We thank Vishva Dixit for sharing unpublished results. M.G.-H. is supported by a fellowship from the Danish Cancer Society. M.M.S. is supported by a HFSP Career Developmental Award, Fondazione San Paolo and Regione Piemonte.

Author information

Author notes

  1. Mads Gyrd-Hansen

    Present address: Current address: Biotech Research and Innovation Centre, University of Copenhagen, Ole Maaloees Vej 5, DK-2200 Copenhagen, Denmark.,

  2. Mads Gyrd-Hansen and Maurice Darding: These authors contributed equally to this work.

Authors and Affiliations

  1. The Breakthrough Toby Robins Breast Cancer Research Centre, Institute of Cancer Research, Mary-Jean Mitchell Green Building, Chester Beatty Laboratories, Fulham Road, London, SW3 6JB, UK

    Mads Gyrd-Hansen, Maurice Darding, Tencho Tenev, Marketa Zvelebil & Pascal Meier

  2. Department of Biochemistry, Level 4 RL Reid Building, La Trobe University, 3086, Victoria, Australia

    Maria Miasari & John Silke

  3. Molecular Biotechnology Center, University of Torino, Torino, 10126, Italy

    Massimo M. Santoro

  4. Department of Environmental and Life Sciences, University of Piemonte Orientale, Alessandria, 15100, Italy

    Massimo M. Santoro

  5. Cold Spring Harbor Laboratory, NY-11724, USA

    Lars Zender, Wen Xue & Scott Lowe

  6. Helmholtz Centre for Infection Research, Braunschweig, 38124, Germany

    Wen Xue

  7. Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, 30625, Germany

    Janusz M. Bujnicki

  8. Section of Structural Biology, The Institute of Cancer Research, Chester Beatty Laboratories, Fulham Road, London, SW3 6JB, UK

    Paula C.A. da Fonseca

  9. International Institute of Molecular and Cell Biology in Warsaw, ul. Trojdena 4, 02-109 Warsaw, and Adam Mickiewicz University, ul. Umultowska 89, Poznan, 61-614, Poland

    Wen Xue

Authors
  1. Mads Gyrd-Hansen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maurice Darding
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Maria Miasari
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Massimo M. Santoro
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Lars Zender
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Wen Xue
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Tencho Tenev
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Paula C.A. da Fonseca
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Marketa Zvelebil
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Janusz M. Bujnicki
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Scott Lowe
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. John Silke
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Pascal Meier
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

M.G.-H. and M.D. performed all experiments, except for those in Fig. 4; M.M. and J.S. planned and performed the cIAP1−/− MEF reconstitution assay; M.M.S. planned and performed the zebrafish reconstitution assay; L.Z., W.X. and S.L. designed, performed and supervised the cIAP1 mouse tumour assay; T.T. provided various constructs and technical support; P.C.A.F. performed sequence alignments and database searches with structural prediction algorithms; J.M.B and M.Z. performed 3D modelling and sequence analysis; M.G.-H. and P.M. designed and supervised the study and wrote the paper.

Corresponding authors

Correspondence to Mads Gyrd-Hansen or Pascal Meier.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Information

Supplementary Information (PDF 5765 kb)

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Gyrd-Hansen, M., Darding, M., Miasari, M. et al. IAPs contain an evolutionarily conserved ubiquitin-binding domain that regulates NF-κB as well as cell survival and oncogenesis. Nat Cell Biol 10, 1309–1317 (2008). https://doi.org/10.1038/ncb1789

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncb1789

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing